Multi-country outbreak of severe acute hepatitis amongst children
Public health authorities globally are exploring possible causative agents for the current paediatric hepatitis outbreak.
By
Gastrointestinal
Latest in
Gastrointestinal
Citius enrols first subject in Phase IIb trial of Halo-Lido for haemorrhoids
The company anticipates results from the trial of Halo-Lido in the second half of next year.
Gannex doses first subject in Phase II primary biliary cholangitis trial
On concluding the Phase II trial, Gannex intends to launch the Phase III trial in the US, China and European…
ILIAS obtains approval for Phase I trial of CSA-AKI asset in Australia
The Phase I trial will assess the safety and tolerability of ILB-202 in healthy adult subjects.
Sirnaomics initiates dosing in Phase I primary sclerosing cholangitis trial
The trial will enrol up to 50 healthy participants of the age 18 to 55 years to assess 3, 6,…
Altimmune commences enrolment in Phase II trial of obesity treatment
The relative change from baseline in body weight at 48 weeks following pemvidutide treatment is the trial’s primary endpoint.
Pipeline Moves: Arog Pharma terminates early-phase cancer trial, progress prospects tumble
Mesoblast in ulcerative colitis and Sage in major depressive disorder are also reviewed by Clinical Trials Arena.
By
Iterative Scopes and Pfizer enter AI-driven agreement to support IBD trials
Under the agreement, Iterative Scopes will gain access to an IBD clinical trial database of Pfizer.